[eLD3-Live] Keeping up with IRA
Pricing: Free for Members and $50 for Non-Members
Program Description
Going into the second half of 2023, the Inflation Reduction Act (IRA) continues to foreshadow potential changes for every health care stakeholder from Medicare beneficiaries to commercial plans, manufacturers, and everything in between. It may be tempting to think that the IRA will have a limited impact outside of Medicare, but that is not the case. How will IRA affect commercial plans and manufacturers? What are the newest regulatory updates from the Department of Health and Human Services?
This session will provide up-to-date insight into how IRA will leave its mark outside of Medicare, explore initial signs of pricing strategies from manufacturers, and help attendees stay up-to-date on recent actions towards drug price negotiation.
Target Audience
This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Summarize the key drug pricing provisions and timeline of implementation of the Inflation Reduction Act (IRA).
- Describe how CMS plans to approach drug pricing negotiations.
- Discuss recent lawsuits challenging government negotiation of prescription drug prices and their impact on drug price negotiations for 2026.
- Explain how government negotiation of prescription drug prices will impact the generic and biosimilar markets and commercial health plans.
Speaker:
Melissa Andel, MPP
Principal
CommonHealth Solutions LLC
Moderator:
Drake Reiter, PharmD
Advisor, Pharmacy Product & Trend
Priority Health
Financial Relationship Disclosures:
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Melissa Andel, MPP Presenter | None |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
ACPE UAN:
Activity Type: Knowledge-Based
Contact Hours: 1
Release Date:
Expiration Date:
Activity Fee: Free for Members and $50 for Non-Members
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.